1 | inclusion | 15,279 |
2 | inclusion/exclusion | 212 |
3 | non-entry | 11 |
4 | nyvad | 8 |
5 | non-inclusion | 7 |
6 | nonentry | 5 |
7 | algren | 4 |
8 | mrdneg | 4 |
9 | nonenrollment | 4 |
10 | ra-diagnosis | 4 |
11 | bioapplications | 3 |
12 | ccmd-3 | 3 |
13 | eligibility/exclusion | 3 |
14 | exclusion/inclusion | 3 |
15 | outmigration | 3 |
16 | oz/o | 3 |
17 | re-inspection | 3 |
18 | s-didesmethylcitalopram | 3 |
19 | 'eligibility | 2 |
20 | a371v | 2 |
21 | bccedp | 2 |
22 | c.1576dup | 2 |
23 | c282y/h63d | 2 |
24 | cheson | 2 |
25 | cleaning-heat | 2 |
26 | comorbidty | 2 |
27 | cyp-enzymes | 2 |
28 | ellenbogen-karlin | 2 |
29 | isshp | 2 |
30 | neuhauser | 2 |
31 | point-mutations | 2 |
32 | return-to-sports | 2 |
33 | s-e-selectin | 2 |
34 | search-terms | 2 |
35 | sternbach | 2 |
36 | usphs-modified | 2 |
37 | usphsmodified | 2 |
38 | 'maastricht-amsterdam | 1 |
39 | 1-5-yr-olds | 1 |
40 | 3×1 | 1 |
41 | abo-incompatibility | 1 |
42 | ahcq | 1 |
43 | ai-evds | 1 |
44 | allocation-decisions | 1 |
45 | arc1987 | 1 |
46 | axon-guidance | 1 |
47 | balneotherapy/hydrotherapy | 1 |
48 | bias-mitigation | 1 |
49 | bradford-hill | 1 |
50 | centre-effects | 1 |
51 | clic5 | 1 |
52 | co-despoisoning | 1 |
53 | condylomatoses | 1 |
54 | csa-adhesion | 1 |
55 | cyp81f4 | 1 |
56 | cytogenicity | 1 |
57 | d-optimality | 1 |
58 | detailed-oriented | 1 |
59 | dsm-iii-r/-iv | 1 |
60 | dsmiii-r | 1 |
61 | d’amico | 1 |
62 | d₂/₃-receptors | 1 |
63 | east-meets-west | 1 |
64 | efns/pns | 1 |
65 | ema/chmp | 1 |
66 | erk/14-3-3epsilon | 1 |
67 | eshre-asrm | 1 |
68 | exclusion-inclusion | 1 |
69 | excursion-time | 1 |
70 | fdo1 | 1 |
71 | fdo2 | 1 |
72 | finmonica | 1 |
73 | fluid-resistance | 1 |
74 | fndh | 1 |
75 | full-study | 1 |
76 | gds/fast | 1 |
77 | gentamicin-inactivation | 1 |
78 | goms | 1 |
79 | henrywin | 1 |
80 | hiv-therapy | 1 |
81 | icd-10-diagnostic | 1 |
82 | ihs-r | 1 |
83 | immunoresponses | 1 |
84 | lambda-x | 1 |
85 | m-1/m-2 | 1 |
86 | mab-sequestration | 1 |
87 | maxima∕minima | 1 |
88 | mccloskey-kanis | 1 |
89 | mean-fold-increase | 1 |
90 | med-ped | 1 |
91 | mi-definition | 1 |
92 | mindfulness-therapy | 1 |
93 | mir-155/mir-155* | 1 |
94 | mr/dd | 1 |
95 | nad-specificity | 1 |
96 | neary | 1 |
97 | niaid/faan | 1 |
98 | nidu-reduction | 1 |
99 | nincds/airen | 1 |
100 | non-gs | 1 |
101 | non-isotopic | 1 |
102 | non-sc | 1 |
103 | noniferiority | 1 |
104 | norgep | 1 |
105 | or=three | 1 |
106 | pigeon-breeding | 1 |
107 | pogrel | 1 |
108 | posti | 1 |
109 | pupil-testing | 1 |
110 | radiation-exposure | 1 |
111 | readiness-for-discharge | 1 |
112 | recearch | 1 |
113 | resaturation | 1 |
114 | rs1805018 | 1 |
115 | rs1838452 | 1 |
116 | rs2301475 | 1 |
117 | rs9679290 | 1 |
118 | silberstein-lipton | 1 |
119 | sokolow-lyons | 1 |
120 | state-independence | 1 |
121 | study-selecting | 1 |
122 | thai-fda | 1 |
123 | theirinclusion | 1 |
124 | trpm-2/clusterin | 1 |
125 | twardowski | 1 |
126 | ultra-dry | 1 |
127 | us.even | 1 |
128 | v-csm | 1 |
129 | varenicline/coaching | 1 |
130 | vas-rest | 1 |
131 | wbrt-planning | 1 |
132 | wear-measurements | 1 |
133 | who/nih | 1 |
134 | yees | 1 |
135 | zatuchni-andros | 1 |
1 | 'eligibility | 2 |
2 | 'maastricht-amsterdam | 1 |
3 | 1-5-yr-olds | 1 |
4 | 3×1 | 1 |
5 | a371v | 2 |
6 | abo-incompatibility | 1 |
7 | ahcq | 1 |
8 | ai-evds | 1 |
9 | algren | 4 |
10 | allocation-decisions | 1 |
11 | arc1987 | 1 |
12 | axon-guidance | 1 |
13 | balneotherapy/hydrotherapy | 1 |
14 | bccedp | 2 |
15 | bias-mitigation | 1 |
16 | bioapplications | 3 |
17 | bradford-hill | 1 |
18 | c.1576dup | 2 |
19 | c282y/h63d | 2 |
20 | ccmd-3 | 3 |
21 | centre-effects | 1 |
22 | cheson | 2 |
23 | cleaning-heat | 2 |
24 | clic5 | 1 |
25 | co-despoisoning | 1 |
26 | comorbidty | 2 |
27 | condylomatoses | 1 |
28 | csa-adhesion | 1 |
29 | cyp-enzymes | 2 |
30 | cyp81f4 | 1 |
31 | cytogenicity | 1 |
32 | d-optimality | 1 |
33 | detailed-oriented | 1 |
34 | dsm-iii-r/-iv | 1 |
35 | dsmiii-r | 1 |
36 | d’amico | 1 |
37 | d₂/₃-receptors | 1 |
38 | east-meets-west | 1 |
39 | efns/pns | 1 |
40 | eligibility/exclusion | 3 |
41 | ellenbogen-karlin | 2 |
42 | ema/chmp | 1 |
43 | erk/14-3-3epsilon | 1 |
44 | eshre-asrm | 1 |
45 | exclusion-inclusion | 1 |
46 | exclusion/inclusion | 3 |
47 | excursion-time | 1 |
48 | fdo1 | 1 |
49 | fdo2 | 1 |
50 | finmonica | 1 |
51 | fluid-resistance | 1 |
52 | fndh | 1 |
53 | full-study | 1 |
54 | gds/fast | 1 |
55 | gentamicin-inactivation | 1 |
56 | goms | 1 |
57 | henrywin | 1 |
58 | hiv-therapy | 1 |
59 | icd-10-diagnostic | 1 |
60 | ihs-r | 1 |
61 | immunoresponses | 1 |
62 | inclusion | 15,279 |
63 | inclusion/exclusion | 212 |
64 | isshp | 2 |
65 | lambda-x | 1 |
66 | m-1/m-2 | 1 |
67 | mab-sequestration | 1 |
68 | maxima∕minima | 1 |
69 | mccloskey-kanis | 1 |
70 | mean-fold-increase | 1 |
71 | med-ped | 1 |
72 | mi-definition | 1 |
73 | mindfulness-therapy | 1 |
74 | mir-155/mir-155* | 1 |
75 | mr/dd | 1 |
76 | mrdneg | 4 |
77 | nad-specificity | 1 |
78 | neary | 1 |
79 | neuhauser | 2 |
80 | niaid/faan | 1 |
81 | nidu-reduction | 1 |
82 | nincds/airen | 1 |
83 | non-entry | 11 |
84 | non-gs | 1 |
85 | non-inclusion | 7 |
86 | non-isotopic | 1 |
87 | non-sc | 1 |
88 | nonenrollment | 4 |
89 | nonentry | 5 |
90 | noniferiority | 1 |
91 | norgep | 1 |
92 | nyvad | 8 |
93 | or=three | 1 |
94 | outmigration | 3 |
95 | oz/o | 3 |
96 | pigeon-breeding | 1 |
97 | pogrel | 1 |
98 | point-mutations | 2 |
99 | posti | 1 |
100 | pupil-testing | 1 |
101 | ra-diagnosis | 4 |
102 | radiation-exposure | 1 |
103 | re-inspection | 3 |
104 | readiness-for-discharge | 1 |
105 | recearch | 1 |
106 | resaturation | 1 |
107 | return-to-sports | 2 |
108 | rs1805018 | 1 |
109 | rs1838452 | 1 |
110 | rs2301475 | 1 |
111 | rs9679290 | 1 |
112 | s-didesmethylcitalopram | 3 |
113 | s-e-selectin | 2 |
114 | search-terms | 2 |
115 | silberstein-lipton | 1 |
116 | sokolow-lyons | 1 |
117 | state-independence | 1 |
118 | sternbach | 2 |
119 | study-selecting | 1 |
120 | thai-fda | 1 |
121 | theirinclusion | 1 |
122 | trpm-2/clusterin | 1 |
123 | twardowski | 1 |
124 | ultra-dry | 1 |
125 | us.even | 1 |
126 | usphs-modified | 2 |
127 | usphsmodified | 2 |
128 | v-csm | 1 |
129 | varenicline/coaching | 1 |
130 | vas-rest | 1 |
131 | wbrt-planning | 1 |
132 | wear-measurements | 1 |
133 | who/nih | 1 |
134 | yees | 1 |
135 | zatuchni-andros | 1 |
1 | mir-155/mir-155* | 1 |
2 | rs9679290 | 1 |
3 | fdo1 | 1 |
4 | 3×1 | 1 |
5 | m-1/m-2 | 1 |
6 | rs1838452 | 1 |
7 | fdo2 | 1 |
8 | ccmd-3 | 3 |
9 | cyp81f4 | 1 |
10 | rs2301475 | 1 |
11 | clic5 | 1 |
12 | arc1987 | 1 |
13 | rs1805018 | 1 |
14 | finmonica | 1 |
15 | thai-fda | 1 |
16 | maxima∕minima | 1 |
17 | non-isotopic | 1 |
18 | icd-10-diagnostic | 1 |
19 | non-sc | 1 |
20 | c282y/h63d | 2 |
21 | nyvad | 8 |
22 | mr/dd | 1 |
23 | usphs-modified | 2 |
24 | usphsmodified | 2 |
25 | med-ped | 1 |
26 | detailed-oriented | 1 |
27 | axon-guidance | 1 |
28 | fluid-resistance | 1 |
29 | state-independence | 1 |
30 | or=three | 1 |
31 | readiness-for-discharge | 1 |
32 | excursion-time | 1 |
33 | radiation-exposure | 1 |
34 | mean-fold-increase | 1 |
35 | mrdneg | 4 |
36 | pigeon-breeding | 1 |
37 | varenicline/coaching | 1 |
38 | wbrt-planning | 1 |
39 | co-despoisoning | 1 |
40 | study-selecting | 1 |
41 | pupil-testing | 1 |
42 | sternbach | 2 |
43 | recearch | 1 |
44 | fndh | 1 |
45 | who/nih | 1 |
46 | twardowski | 1 |
47 | posti | 1 |
48 | pogrel | 1 |
49 | bradford-hill | 1 |
50 | 'maastricht-amsterdam | 1 |
51 | s-didesmethylcitalopram | 3 |
52 | eshre-asrm | 1 |
53 | v-csm | 1 |
54 | niaid/faan | 1 |
55 | algren | 4 |
56 | nincds/airen | 1 |
57 | us.even | 1 |
58 | ellenbogen-karlin | 2 |
59 | trpm-2/clusterin | 1 |
60 | s-e-selectin | 2 |
61 | henrywin | 1 |
62 | csa-adhesion | 1 |
63 | inclusion | 15,279 |
64 | exclusion-inclusion | 1 |
65 | non-inclusion | 7 |
66 | exclusion/inclusion | 3 |
67 | theirinclusion | 1 |
68 | inclusion/exclusion | 212 |
69 | eligibility/exclusion | 3 |
70 | bias-mitigation | 1 |
71 | outmigration | 3 |
72 | mab-sequestration | 1 |
73 | resaturation | 1 |
74 | gentamicin-inactivation | 1 |
75 | re-inspection | 3 |
76 | nidu-reduction | 1 |
77 | mi-definition | 1 |
78 | erk/14-3-3epsilon | 1 |
79 | cheson | 2 |
80 | silberstein-lipton | 1 |
81 | oz/o | 3 |
82 | d’amico | 1 |
83 | bccedp | 2 |
84 | norgep | 1 |
85 | isshp | 2 |
86 | ema/chmp | 1 |
87 | c.1576dup | 2 |
88 | ahcq | 1 |
89 | dsmiii-r | 1 |
90 | ihs-r | 1 |
91 | neuhauser | 2 |
92 | 1-5-yr-olds | 1 |
93 | ai-evds | 1 |
94 | yees | 1 |
95 | cyp-enzymes | 2 |
96 | immunoresponses | 1 |
97 | condylomatoses | 1 |
98 | non-gs | 1 |
99 | mccloskey-kanis | 1 |
100 | ra-diagnosis | 4 |
101 | goms | 1 |
102 | search-terms | 2 |
103 | allocation-decisions | 1 |
104 | bioapplications | 3 |
105 | point-mutations | 2 |
106 | sokolow-lyons | 1 |
107 | efns/pns | 1 |
108 | zatuchni-andros | 1 |
109 | d₂/₃-receptors | 1 |
110 | centre-effects | 1 |
111 | wear-measurements | 1 |
112 | return-to-sports | 2 |
113 | cleaning-heat | 2 |
114 | nonenrollment | 4 |
115 | gds/fast | 1 |
116 | vas-rest | 1 |
117 | east-meets-west | 1 |
118 | a371v | 2 |
119 | dsm-iii-r/-iv | 1 |
120 | lambda-x | 1 |
121 | full-study | 1 |
122 | mindfulness-therapy | 1 |
123 | hiv-therapy | 1 |
124 | balneotherapy/hydrotherapy | 1 |
125 | neary | 1 |
126 | ultra-dry | 1 |
127 | non-entry | 11 |
128 | nonentry | 5 |
129 | comorbidty | 2 |
130 | nad-specificity | 1 |
131 | cytogenicity | 1 |
132 | d-optimality | 1 |
133 | 'eligibility | 2 |
134 | abo-incompatibility | 1 |
135 | noniferiority | 1 |